- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01921517
Micromechanical Modeling Using Low Magnitude Mechanical Stimulation (LMMS)
Osteoporosis Treatment Response Assessed by Micromechanical Modeling of MRI Data
The response to a daily 10 minute session of low-magnitude mechanical stimulation (LMMS) on bone in 100 postmenopausal women ages 45-65 years will be evaluated at baseline and 12 months using high-resolution magnetic resonance (MR) imaging. Subjects will be assigned to an active platform that produces vibrations or to a placebo platform that produces no vibrations.
The investigators propose to evaluate the hypothesis that LMMS applied to postmenopausal women ages 45-65 improves the mechanical integrity of bone while lowering marrow adiposity.
- The investigators will optimize an integrated imaging protocol for high-resolution structural MR imaging of the distal tibia and spectroscopic imaging-based quantification of bone marrow composition in the lumbar vertebrae.
- The investigators will further develop and validate micro-finite-element (FE) analysis for quantitative assessment of trabecular and cortical bone stiffness and failure load from high-resolution MR images of the distal tibia.
- The investigators will apply the methodology of Aims 1 and 2 (above) in a double-blinded, randomized, placebo-controlled study to a cohort of 100 healthy postmenopausal women in the age range of 45-65 years, studied at baseline and 12 months after having been subjected to 10 minutes daily of either 30 Hz/0.3g stimulation or placebo treatment, monitored rigorously via electronic feedback.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Weightbearing exercise has an osteogenic effect by reducing bone resorption and enhancing bone formation. During the past several years a number of articles have appeared demonstrating that low-magnitude mechanical stimulation (LMMS) is osteogenic in animals and also in humans. Preclinical studies have also demonstrated an effect of decrease in adiposity. The mechanobiology underlying these phenomena is beginning to emerge in terms of expression of genes stimulated by the action of the vibrations to which osteocytes and adipocytes are subjected.
If successful, LMMS treatment, a non-pharmacologic intervention, could prevent bone loss and potentially stimulate bone formation and decreased adipocyte production resulting in increased bone strength and reduced fracture susceptibility in subjects at risk of developing osteoporosis. The proposed project focuses directly on measures of strength by evaluating the therapeutic response in terms of magnetic resonance (MR) image-based micro finite-element (FE) assessment of bone stiffness and failure strength, along with quantifying treatment-induced changes in marrow adiposity, as part of a single, integrated examination, conducted at baseline and 12 months of treatment in a double-blinded, randomized, placebo-controlled study of early postmenopausal women.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Hospital of the University of Pennsylvania
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Females, ages 45-65 years and post menopausal, as defined by a history of amenorrhea for a minimum of 24 months and a serum FSH (follicle-stimulating hormone) concentration of 25 mIU/mL (milli-International unit per milliliter) and negative pregnancy test.
Exclusion Criteria:
- Current or prior use of medications known to affect bone (e.g. bisphosphonates, calcitonin, selective estrogen receptor modulators, denosumab, diphenylhydantoin, recent systemic glucocorticoid use), bone mineral density T score of less than -2.5 and greater than +2, Vitamin D level less then 12 ng/ml, BMI (body mass index) of greater than 32, current alcohol or drug abuse: more than 3 alcoholic beverages per day or current abuse of illicit drugs or prescription medication, uncontrolled or untreated cardiac or pulmonary disease liver disease: history of hepatitis or ALT (alanine aminotransferase) or AST (aspartate aminotransferase) greater than 2x ULN (upper limit of normal), renal disease: history of renal disease or serum creatinine greater than 2x ULN diabetes, pacemaker or metallic implants considered a contraindication to MR scanning.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Low Magnitude Mechanical Stimulation
10 minutes daily of 30 Hz/0.3g stimulation using a vibrating platform.
|
Mechanical stimulation for 10 minutes daily for 12 months at a frequency of 30 Hz and acceleration of 0.3 g.
|
Placebo Comparator: Sham Low Magnitude Mechanical Stimulation
10 minutes daily of placebo treatment using a sham vibrating platform.
|
Mechanical stimulation for 10 minutes daily for 12 months using a sham device.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Distal Tibia Bone Quality
Time Frame: Baseline to 12 months
|
Distal tibial bone quality is measured through MRI by calculating the ratio between bone volume to total volume.
A lower value would indicate osteoporotic (weaker) bone; a higher value would indicate healthy (normal) bone.
|
Baseline to 12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Felix W Wehrli, Ph.D., University of Pennsylvania
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 3408455
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bone Alteration
-
United States Army Research Institute of Environmental...United States Department of DefenseCompletedDietary Modification | Bone AlterationUnited States
-
BioMed Valley Discoveries, IncTerminatedAdvanced Solid Tumor | MAP2K1 Gene Mutation | BRAF Gene Mutation | MEK Mutation | BRAF Gene Alteration | MEK Alteration | MAP2K1 Gene Alteration | MAP2K2 Gene Mutation | MAP2K2 Gene AlterationUnited States
-
Cairo UniversityUnknown
-
Danone Asia Pacific Holdings Pte, Ltd.CompletedImmunologic Activity Alteration
-
Children's Hospital of PhiladelphiaNational Institute of Neurological Disorders and Stroke (NINDS)Completed
-
National Taiwan University HospitalCompletedAlteration of Cognitive FunctionTaiwan
-
Northumbria UniversityCompletedAlteration of Cognitive FunctionUnited Kingdom
-
University of California, IrvineBeckman Laser Institute University of California Irvine; Unilever R&DCompletedCollagen Fibril AlterationUnited States
-
University of Sao PauloUnknown
-
Ramathibodi HospitalCompletedAlteration of Modified Mallampati Score
Clinical Trials on Low Magnitude Mechanical Stimulation
-
Hebrew SeniorLifeNational Institute on Aging (NIA)CompletedOsteopeniaUnited States
-
Boston Children's HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedAnorexia NervosaUnited States
-
Children's Hospital of PhiladelphiaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedCrohn DiseaseUnited States
-
National Institute of Diabetes and Digestive and...CompletedRenal OsteodystrophyUnited States
-
Prince of Wales Hospital, Shatin, Hong KongChinese University of Hong KongCompletedDistal Radius Fracture | Fall PatientsHong Kong
-
Chinese University of Hong KongCompleted
-
Prince of Wales Hospital, Shatin, Hong KongTai Po HospitalRecruiting
-
Children's Hospital Los AngelesNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedCerebral PalsyUnited States
-
Chinese University of Hong KongCompleted
-
University of DelawareEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedCerebral Palsy | Muscle SpasticityUnited States